Peptides stocked at betterbiosynthesis.com
20 peptides currently tracked
Synthetic analog of the growth-hormone 176–191 lipolytic region — developed by Metabolic Pharmaceuticals and the vers…
Synthetic 15-amino acid peptide derived from a gastric protein, researched for tissue repair, gut healing, tendon rec…
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) researched for telomerase activation, telomere elongation, and potential ant…
Copper-binding tripeptide researched for skin regeneration, wound healing, collagen stimulation, and anti-aging effects.
Selective growth hormone secretagogue (GHS) that stimulates pulsatile GH release with minimal effects on cortisol and…
Anti-inflammatory tripeptide from α-MSH researched for gut health, skin barrier repair, and NF-κB inhibition.
The only human cathelicidin antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi.
Mitochondrial-derived peptide researched for metabolic regulation, exercise mimicry, insulin sensitivity, and longevity.
Nicotinamide adenine dinucleotide, a coenzyme essential for cellular energy metabolism, DNA repair, and sirtuin activ…
Melanocortin receptor agonist (bremelanotide) FDA-approved as Vyleesi® for hypoactive sexual desire disorder in preme…
Synthetic heptapeptide derived from tuftsin, researched for anxiolytic effects, immune modulation, and cognitive enha…
Synthetic heptapeptide derived from ACTH(4-10), researched for neuroprotection, cognitive enhancement, and brain inju…
Synthetic 29-amino acid GHRH analog, the first FDA-approved GH-releasing peptide (Geref®). Stimulates natural pulsati…
Mitochondria-targeted tetrapeptide researched for restoring cellular energy production, reducing oxidative stress, an…
Synthetic fragment of Thymosin Beta-4 researched for tissue repair, inflammation reduction, wound healing, and cardia…
Synthetic growth hormone-releasing hormone (GHRH) analog, FDA-approved as Egrifta® for HIV-associated lipodystrophy. …
Thymic peptide researched for immune modulation, T-cell activation, and antiviral response. Approved in over 35 count…